{"transactions":[{"id":4622396,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-09-18T00:46:25.000Z","date":"2026-09-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option fully vested on 06/11/2025 from the date of grant (06-11-2024)."}],"balance_after":0,"derivative":{"exercise_price":0.12,"exercise_date":"2025-06-11","expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-26-007223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355790/000168316826007223/ownership.xml","form_type":"4"}},{"id":4617883,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T20:12:10.000Z","date":"2026-09-11","kind":"sale","planned":false,"acquired":false,"shares":32802,"price":0.32,"value":10496.64,"ownership":{"direct":false,"nature":"Through family Trust dated 4/21/2000"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001683168-26-007164","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1355790/000168316826007164/ownership.xml","form_type":"4"}},{"id":672004,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option vested in four equal quarterly installments from the date of grant (02-20-2019) until fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.31,"exercise_date":"2019-02-20","expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":672003,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested in 48 equal monthly installments from the date of grant (2-07-2022) until fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.78,"exercise_date":"2022-02-07","expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":672002,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":7.31,"value":91375.0,"ownership":{"direct":true},"balance_after":72245,"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":672001,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":128,"price":61.77,"value":7906.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $61.10 to $61.98. The price reported above reflects the weighted average sales price."}],"balance_after":59745,"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":672000,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":13485,"price":60.21,"value":811931.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $60.00 to $61.00. The price reported above reflects the weighted average sales price."}],"balance_after":59873,"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":671999,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":36387,"price":58.64,"value":2133733.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $58.50 to $58.97.  The price reported above reflects the weighted average sales price."}],"balance_after":73358,"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":671998,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-31T20:06:45.000Z","date":"2026-08-28","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":3.78,"value":189000.0,"ownership":{"direct":true},"balance_after":109745,"source":{"system":"sec-edgar","filing":"0001437749-26-029308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029308/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-28"}},{"id":672982,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2026-08-28T20:51:30.000Z","date":"2026-08-28","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vested in 48 equal monthly installments from the date of grant (2-07-2022) until fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.78,"exercise_date":"2022-02-07","expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-029196","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/rdgdoc.xml","form_type":"4"}},{"id":672981,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T20:51:30.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":128,"price":61.77,"value":7906.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $61.10 to $61.98. The price reported above reflects the weighted average sales price."}],"balance_after":59745,"source":{"system":"sec-edgar","filing":"0001437749-26-029196","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/rdgdoc.xml","form_type":"4"}},{"id":672980,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T20:51:30.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":13485,"price":60.21,"value":811931.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $60.00 to $61.00. The price reported above reflects the weighted average sales price."}],"balance_after":59873,"source":{"system":"sec-edgar","filing":"0001437749-26-029196","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/rdgdoc.xml","form_type":"4"}},{"id":672979,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T20:51:30.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":36387,"price":58.64,"value":2133733.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $58.50 to $58.97.  The price reported above reflects the weighted average sales price."}],"balance_after":73358,"source":{"system":"sec-edgar","filing":"0001437749-26-029196","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/rdgdoc.xml","form_type":"4"}},{"id":672978,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-28T20:51:30.000Z","date":"2026-08-28","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":3.78,"value":189000.0,"ownership":{"direct":true},"balance_after":109745,"source":{"system":"sec-edgar","filing":"0001437749-26-029196","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926029196/rdgdoc.xml","form_type":"4"}},{"id":697219,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-04T20:57:23.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-025700","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926025700/rdgdoc.xml","form_type":"4"}},{"id":729025,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T00:30:51.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":182584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying such option shall vest in equal quarterly increments through June 11, 2027, with the first increment vesting on September 11, 2026."}],"balance_after":182584,"derivative":{"exercise_price":0.178,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":182584},"source":{"system":"sec-edgar","filing":"0001683168-26-005073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316826005073/ownership.xml","form_type":"4"}},{"id":729024,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T00:30:51.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying such option shall vest on the earlier of (a) June 11, 2027, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":0.17,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-26-005073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316826005073/ownership.xml","form_type":"4"}},{"id":939235,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-14T23:06:42.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":7757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in one annual installment beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in one annual installment beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":294253,"derivative":{"underlying":"Common Stock","underlying_shares":7757},"source":{"system":"sec-edgar","filing":"0001437749-26-001294","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001294/rdgdoc.xml","form_type":"4"}},{"id":939234,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-14T23:06:42.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":12196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 12, 2027."}],"balance_after":286496,"derivative":{"exercise_price":15.47,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":12196},"source":{"system":"sec-edgar","filing":"0001437749-26-001294","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001294/rdgdoc.xml","form_type":"4"}},{"id":1104912,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T12:18:43.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":532786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying such option shall vest in equal quarterly increments through June 17, 2026, with the first increment vesting on September 17, 2025."}],"balance_after":532786,"derivative":{"exercise_price":0.13,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":532786},"source":{"system":"sec-edgar","filing":"0001683168-25-004620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316825004620/ownership.xml","form_type":"4"}},{"id":1104911,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T12:18:43.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying such option shall vest on the earlier of (a) June 17, 2026, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":0.13,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-25-004620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316825004620/ownership.xml","form_type":"4"}},{"id":1310766,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-06T21:18:58.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest equally on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 3, 2026."}],"balance_after":25000,"derivative":{"exercise_price":13,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-000459","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925000459/rdgdoc.xml","form_type":"4"}},{"id":1480469,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:03:55.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":361111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest in four equal quarterly increments, beginning September 11, 2024."}],"balance_after":361111,"derivative":{"exercise_price":0.12,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":361111},"source":{"system":"sec-edgar","filing":"0001683168-24-004176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316824004176/ownership.xml","form_type":"4"}},{"id":1480468,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:03:55.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest on the earlier of (i) June 11, 2025 or (ii) the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":30000,"derivative":{"exercise_price":0.12,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-24-004176","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316824004176/ownership.xml","form_type":"4"}},{"id":1589459,"issuer":{"id":93373,"kind":"organization","name":"Ambrx Biopharma, Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-03-07T17:34:26.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Merger Consideration, was cancelled and converted into the right to receive an amount in cash (without interest and less any applicable withholding taxes) equal to the product of (i) the aggregate number of shares of Company Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the Per Share Exercise Price of such Company Option. Each Company Option that had a Per Share Exercise Price that was equal to or exceeded the amount of the Merger Consideration at the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These Company Options are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-028171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1990550/000095017024028171/ownership.xml","form_type":"4"}},{"id":1589458,"issuer":{"id":93373,"kind":"organization","name":"Ambrx Biopharma, Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-03-07T17:34:26.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Merger Consideration, was cancelled and converted into the right to receive an amount in cash (without interest and less any applicable withholding taxes) equal to the product of (i) the aggregate number of shares of Company Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the Per Share Exercise Price of such Company Option. Each Company Option that had a Per Share Exercise Price that was equal to or exceeded the amount of the Merger Consideration at the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Company Common Stock subject to the options to purchase shares of Company Common Stock (each, a \"Company Option\") vest in thirty-six (36) equal monthly installments following February 2, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.96,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-028171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1990550/000095017024028171/ownership.xml","form_type":"4"}},{"id":1589457,"issuer":{"id":93373,"kind":"organization","name":"Ambrx Biopharma, Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-07T17:34:26.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 5, 2024, among the Issuer, Johnson & Johnson (\"J&J\"), and Charm Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of March 7, 2024 (such date and time of such Merger, the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each of these restricted stock units (\"RSUs\") represents a contingent right to receive one share of common stock of the Issuer (\"Company Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs that was outstanding as of immediately prior to the Effective Time was cancelled and the Reporting Person was entitled to receive the Merger Consideration, without interest and less any applicable withholding taxes, in respect of each such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest as follows: on the earlier of (i) the one year anniversary of the grant date of June 7, 2023, and (ii) the day before the next annual general meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest as follows: on the earlier of (i) the one year anniversary of the grant date of June 7, 2023, and (ii) the day before the next annual general meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12142},"source":{"system":"sec-edgar","filing":"0000950170-24-028171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1990550/000095017024028171/ownership.xml","form_type":"4"}},{"id":1641005,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-15T21:16:41.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 13, 2025."}],"balance_after":164555,"derivative":{"exercise_price":4.42,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-24-004359","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774924004359/rdgdoc.xml","form_type":"4"}},{"id":1851944,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:23:13.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":445205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest in four equal quarterly increments, beginning 09/14/2023."}],"balance_after":445205,"derivative":{"exercise_price":0.14,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":445205},"source":{"system":"sec-edgar","filing":"0001683168-23-004226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316823004226/ownership.xml","form_type":"4"}},{"id":1851943,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:23:13.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest fully at the earlier of (i) 06/14/2024 or (ii) the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":30000,"derivative":{"exercise_price":0.14,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-23-004226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316823004226/ownership.xml","form_type":"4"}},{"id":1860824,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-09T16:05:18.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents seven (7) Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of Restricted Stock Units (the \"RSUs\") payable solely in Ordinary Shares of the Issuer that vest as follows: on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0000899243-23-015152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000089924323015152/doc4.xml","form_type":"4"}},{"id":1973885,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(Right to buy)","published_at":"2023-03-03T21:10:18.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2024."}],"balance_after":134555,"derivative":{"exercise_price":3.47,"expiration_date":"2033-02-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-006674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315223006674/ownership.xml","form_type":"4"}},{"id":2040463,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-31T18:14:54.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":105000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option held by the reporting person was amended to reduce the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Ordinary Shares subject to the option will vest on the earlier of (i) July 8, 2023, or (ii) the day immediately prior to the date of the next Annual Grant Date as defined in the Company's Non-Employee Director Compensation Policy."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents seven Ordinary Shares of the Issuer."}],"balance_after":105000,"derivative":{"exercise_price":0.28,"expiration_date":"2032-07-07","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-23-005790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000120919123005790/doc4.xml","form_type":"4"}},{"id":2040462,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-31T18:14:54.000Z","date":"2023-01-27","kind":"disposition_to_issuer","acquired":false,"shares":105000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option held by the reporting person was amended to reduce the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Ordinary Shares subject to the option will vest on the earlier of (i) July 8, 2023, or (ii) the day immediately prior to the date of the next Annual Grant Date as defined in the Company's Non-Employee Director Compensation Policy."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents seven Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.43,"expiration_date":"2032-07-07","underlying":"Ordinary Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-23-005790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000120919123005790/doc4.xml","form_type":"4"}},{"id":2040461,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-31T18:14:54.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":210000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option held by the reporting person was amended to reduce the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Ordinary Shares subject to the option vest in thirty-six equal monthly installments following February 2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents seven Ordinary Shares of the Issuer."}],"balance_after":210000,"derivative":{"exercise_price":0.28,"expiration_date":"2032-02-01","underlying":"Ordinary Shares","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001209191-23-005790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000120919123005790/doc4.xml","form_type":"4"}},{"id":2040460,"issuer":{"id":109604,"kind":"organization","name":"Ambrx Biopharma Inc.","symbol":"AMAM"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-31T18:14:54.000Z","date":"2023-01-27","kind":"disposition_to_issuer","acquired":false,"shares":210000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option held by the reporting person was amended to reduce the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Ordinary Shares subject to the option vest in thirty-six equal monthly installments following February 2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents seven Ordinary Shares of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":0.66,"expiration_date":"2032-02-01","underlying":"Ordinary Shares","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001209191-23-005790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836056/000120919123005790/doc4.xml","form_type":"4"}},{"id":2235755,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T21:01:01.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) 06/09/2023 or (ii) the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":30000,"derivative":{"exercise_price":0.474,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-004287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316822004287/ownership.xml","form_type":"4"}},{"id":2235754,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T21:01:01.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":139264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/09/2022."}],"balance_after":139264,"derivative":{"exercise_price":0.474,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":139264},"source":{"system":"sec-edgar","filing":"0001683168-22-004287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316822004287/ownership.xml","form_type":"4"}},{"id":2369131,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(Right to buy)","published_at":"2022-02-28T21:36:15.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 7, 2023."}],"balance_after":109555,"derivative":{"exercise_price":3.78,"expiration_date":"2032-02-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-005620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315222005620/ownership.xml","form_type":"4"}},{"id":2671742,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T18:11:17.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 09, 2022 or (ii) the date of the 2022 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control."}],"balance_after":30000,"derivative":{"exercise_price":0.39,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-21-002469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316821002469/ownership.xml","form_type":"4"}},{"id":2671741,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T18:11:17.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":183481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/09/2021."}],"balance_after":183481,"derivative":{"exercise_price":0.39,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":183481},"source":{"system":"sec-edgar","filing":"0001683168-21-002469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316821002469/ownership.xml","form_type":"4"}},{"id":2727404,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(Right to buy)","published_at":"2021-05-05T20:15:38.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":19655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on May 3, 2022."}],"balance_after":59555,"derivative":{"exercise_price":8.61,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":19655},"source":{"system":"sec-edgar","filing":"0001493152-21-010523","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315221010523/ownership.xml","form_type":"4"}},{"id":3098416,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T22:04:14.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":92857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, with first increment vesting on 9/23/2020."}],"balance_after":92857,"derivative":{"exercise_price":1.08,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":92857},"source":{"system":"sec-edgar","filing":"0001683168-20-002089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316820002089/ownership.xml","form_type":"4/A","original_submission_date":"2020-06-24"}},{"id":3100794,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T20:43:36.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 23, 2021 or (ii) the date of the 2021 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control."}],"balance_after":30000,"derivative":{"exercise_price":1.08,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-20-002055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316820002055/ownership.xml","form_type":"4"}},{"id":3100793,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T20:43:36.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":46428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, with first increment vesting on 9/23/2020."}],"balance_after":46428,"derivative":{"exercise_price":1.08,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":46428},"source":{"system":"sec-edgar","filing":"0001683168-20-002055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316820002055/ownership.xml","form_type":"4"}},{"id":3209002,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-16T20:54:36.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":27400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021."}],"balance_after":27400,"derivative":{"exercise_price":3.58,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":27400},"source":{"system":"sec-edgar","filing":"0001493152-20-004056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315220004056/ownership.xml","form_type":"4"}},{"id":3307786,"issuer":{"id":7776,"kind":"organization","name":"FF EAI Robotics Ecosystem Inc."},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-01-17T23:06:38.000Z","date":"2020-01-15","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve (12) equal monthly installments begining on February 15, 2020 with the balance vesting on the 15th day of each calendar month thereafter until vested in full."}],"balance_after":12000,"derivative":{"exercise_price":0.23,"expiration_date":"2030-01-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001382963-20-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460702/000138296320000010/edgar.xml","form_type":"4"}},{"id":3500404,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-05T17:46:43.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 3, 2020 or (ii) the date of the 2020 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control."}],"balance_after":30000,"derivative":{"exercise_price":1.08,"expiration_date":"2019-06-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-19-001799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316819001799/ownership.xml","form_type":"4"}},{"id":3500403,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-05T17:46:43.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":71982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, with first increment vesting on 9/03/2019."}],"balance_after":71982,"derivative":{"exercise_price":1.08,"expiration_date":"2019-06-03","underlying":"Common Stock","underlying_shares":71982},"source":{"system":"sec-edgar","filing":"0001683168-19-001799","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316819001799/ownership.xml","form_type":"4"}},{"id":3551397,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-22T18:12:47.000Z","date":"2019-04-18","kind":"sale","acquired":false,"shares":1350,"price":1.245,"value":1680.75,"ownership":{"direct":true},"balance_after":31710,"source":{"system":"sec-edgar","filing":"0001683168-19-001143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316819001143/ownership.xml","form_type":"4"}},{"id":3604398,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-03-08T21:34:12.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020."}],"balance_after":12500,"derivative":{"exercise_price":7.31,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-018118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919119018118/doc4.xml","form_type":"4"}},{"id":3668010,"issuer":{"id":7776,"kind":"organization","name":"FF EAI Robotics Ecosystem Inc."},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2019-02-08T21:13:23.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve (12) equal monthly installments begining on March 6, 2019 with the balance vesting on the 6th day of each calendar month thereafter until vested in full."}],"balance_after":15000,"derivative":{"exercise_price":0.6,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001382963-19-000015","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460702/000138296319000015/edgar.xml","form_type":"4"}},{"id":3763319,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-16T00:13:19.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":5000,"price":6,"value":30000.0,"ownership":{"direct":true},"balance_after":59745,"source":{"system":"sec-edgar","filing":"0001209191-18-058825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919118058825/doc4.xml","form_type":"4"}},{"id":3884012,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-25T20:18:35.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 21, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control."}],"balance_after":30000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-18-001778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316818001778/ownership.xml","form_type":"4"}},{"id":3884011,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-25T20:18:35.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":38462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/21/2018."}],"balance_after":38462,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":38462},"source":{"system":"sec-edgar","filing":"0001683168-18-001778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316818001778/ownership.xml","form_type":"4"}},{"id":3884010,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2018-06-25T20:18:35.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":8655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant."}],"balance_after":8655,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-21","underlying":"Common Stock","underlying_shares":8655},"source":{"system":"sec-edgar","filing":"0001683168-18-001778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316818001778/ownership.xml","form_type":"4"}},{"id":3970329,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-04-04T06:13:34.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":513,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":513},"source":{"system":"sec-edgar","filing":"0001415889-18-000546","document":"form4a-04042018_030422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000546/form4a-04042018_030422.xml","form_type":"4/A","original_submission_date":"2018-04-03"}},{"id":3970328,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T06:13:34.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."}],"balance_after":23063,"source":{"system":"sec-edgar","filing":"0001415889-18-000546","document":"form4a-04042018_030422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000546/form4a-04042018_030422.xml","form_type":"4/A","original_submission_date":"2018-04-03"}},{"id":3972723,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-03T22:36:34.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":11054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant. Q1 2018."}],"balance_after":11054,"derivative":{"exercise_price":1.47,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":11054},"source":{"system":"sec-edgar","filing":"0001683168-18-000918","document":"maier_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316818000918/maier_frm4.xml","form_type":"4"}},{"id":3973789,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-04-03T18:26:43.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":513,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":513},"source":{"system":"sec-edgar","filing":"0001415889-18-000541","document":"form4-04032018_030429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000541/form4-04032018_030429.xml","form_type":"4"}},{"id":3973788,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T18:26:43.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."}],"balance_after":23462,"source":{"system":"sec-edgar","filing":"0001415889-18-000541","document":"form4-04032018_030429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000541/form4-04032018_030429.xml","form_type":"4"}},{"id":4037411,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-23T15:43:38.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Option award is partial compensation for service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Option award is partial compensation for service as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option Shares shall vest on a monthly basis after the commencement date until fully vested on the one year anniversary of the commencement date."}],"balance_after":35000,"derivative":{"exercise_price":2.04,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-18-000306","document":"form4-02232018_120224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000306/form4-02232018_120224.xml","form_type":"4"}},{"id":4089713,"issuer":{"id":7776,"kind":"organization","name":"FF EAI Robotics Ecosystem Inc."},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-01-26T02:23:03.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve (12) equal monthly installments begining on February 23, 2018 with the balance vesting on the 23rd day of each calendar month thereafter until vested in full."}],"balance_after":30000,"derivative":{"exercise_price":0.34,"expiration_date":"2018-01-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001382963-18-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460702/000138296318000019/edgar.xml","form_type":"4"}},{"id":4091237,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T19:09:04.000Z","date":"2018-01-24","kind":"sale","acquired":false,"shares":17999,"price":0.84,"value":15119.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a portion of the number of shares required to be sold by the reporting person to cover estimated tax obligations in connection with the vesting of the RSUs of the reporting person. This sale is mandated by the Issuer's election, as approved by the Board of Directors, under the equity incentive plan to require satisfaction of estimated tax obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.86 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":68314,"source":{"system":"sec-edgar","filing":"0001415889-18-000116","document":"form4-01242018_040150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000116/form4-01242018_040150.xml","form_type":"4"}},{"id":4091236,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-24T19:09:04.000Z","date":"2018-01-23","kind":"sale","acquired":false,"shares":17449,"price":0.87,"value":15180.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a portion of the number of shares required to be sold by the reporting person to cover estimated tax obligations in connection with the vesting of the RSUs of the reporting person. This sale is mandated by the Issuer's election, as approved by the Board of Directors, under the equity incentive plan to require satisfaction of estimated tax obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.89 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86313,"source":{"system":"sec-edgar","filing":"0001415889-18-000116","document":"form4-01242018_040150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000116/form4-01242018_040150.xml","form_type":"4"}},{"id":4100609,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-01-12T17:22:22.000Z","date":"2018-01-08","kind":"exercise","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on January 8, 2018, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on January 8, 2018, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date."}],"balance_after":1543,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-18-000049","document":"form4-01122018_020109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000049/form4-01122018_020109.xml","form_type":"4"}},{"id":4100608,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-12T17:22:22.000Z","date":"2018-01-08","kind":"exercise","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of such units granted on September 15, 2017 and October 2, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of such units granted on September 15, 2017 and October 2, 2017."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-18-000049","document":"form4-01122018_020109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588918000049/form4-01122018_020109.xml","form_type":"4"}},{"id":4104556,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-08T16:02:35.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options to purchase shares of common stock were issued to the Reporting Person, a non-employee director of Issuer, as an annual stock option grant for his service as a director of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest with respect to 1/12th of the underlying shares monthly, commencing with the first monthly vesting date of February 4, 2018, so that such options are fully vested on January 4, 2019."}],"balance_after":35000,"derivative":{"exercise_price":2.11,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001017491-18-000016","document":"wf-form4_151544534265460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000101749118000016/wf-form4_151544534265460.xml","form_type":"4"}},{"id":4117054,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-02T22:18:44.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":10350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant: Q4 2017."}],"balance_after":10350,"derivative":{"exercise_price":1.6,"expiration_date":"2027-12-29","underlying":"Common Stock","underlying_shares":10350},"source":{"system":"sec-edgar","filing":"0001683168-18-000017","document":"maier_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316818000017/maier_f4.xml","form_type":"4"}},{"id":4192414,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-10-04T06:23:44.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":75790,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements. Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."}],"balance_after":75790,"derivative":{"underlying":"Common Stock","underlying_shares":75790},"source":{"system":"sec-edgar","filing":"0001415889-17-001616","document":"form4-10042017_031033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917001616/form4-10042017_031033.xml","form_type":"4"}},{"id":4197686,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T23:49:27.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":8830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant: Q3 2017."}],"balance_after":8830,"derivative":{"exercise_price":1.8,"expiration_date":"2027-09-29","underlying":"Common Stock","underlying_shares":8830},"source":{"system":"sec-edgar","filing":"0001683168-17-002550","document":"maier_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316817002550/maier_f4.xml","form_type":"4"}},{"id":4207387,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-09-18T17:20:29.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":24210,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements.  Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements.  Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements.  Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Grants of restricted stock units convert on a one-for-one basis into common stock and vest on January 8, 2018 or earlier under provisions of the Company's current equity incentive plan and individual employment agreements.  Grants to management and board of directors are intended to provide incentives to remain at the company during activities related to evaluation of strategic options with an investment advisory bank intended on improving shareholder value and in consideration for potential success resulting from those efforts."}],"balance_after":24210,"derivative":{"underlying":"Common Stock","underlying_shares":24210},"source":{"system":"sec-edgar","filing":"0001415889-17-001503","document":"form4-09182017_050919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917001503/form4-09182017_050919.xml","form_type":"4"}},{"id":4264133,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-05T21:48:58.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":14254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant. Q2 2017"}],"balance_after":14254,"derivative":{"exercise_price":1.2,"expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":14254},"source":{"system":"sec-edgar","filing":"0001683168-17-001723","document":"maier_frm4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316817001723/maier_frm4.xml","form_type":"4"}},{"id":4282463,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-14T16:07:11.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":20000,"price":1.57,"value":31400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatic Annual Grant to Non-Employee Director pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests and becomes exercisable one year after the date of grant, subject to recipient's continued service on the Company's Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":1.57,"expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-17-000979","document":"form4-06142017_010600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000979/form4-06142017_010600.xml","form_type":"4"}},{"id":4295660,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T17:20:09.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option granted as part of compensation for non-employee directors. Options vest fully on the earlier of (i) May 31, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control. All grants have an exercise price of $1.10 per share."}],"balance_after":30000,"derivative":{"exercise_price":1.1,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-17-001478","document":"maier_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316817001478/maier_f4.xml","form_type":"4"}},{"id":4308517,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-05-23T20:12:04.000Z","date":"2017-05-19","kind":"grant","acquired":true,"shares":50000,"price":1.8,"value":90000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable and was issued pursuant to conditions of the Letter Agreement, dated May 15, 2017, by and between the Company and the lead investor in connection with the Company's public offering completed on May 19, 2017, and filed with the Securities and Exchange Commission on May 22, 2017 as Exhibit A of Exhibit 10.2 of the Company's Quarterly Report on Form 10-Q."}],"balance_after":50000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-05-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-17-000846","document":"form4-05232017_050554.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000846/form4-05232017_050554.xml","form_type":"4"}},{"id":4361992,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-04-04T19:22:08.000Z","date":"2017-04-02","kind":"exercise","acquired":false,"shares":1543,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date."}],"balance_after":1543,"derivative":{"underlying":"Common Stock","underlying_shares":1543},"source":{"system":"sec-edgar","filing":"0001415889-17-000592","document":"form4-04042017_040458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000592/form4-04042017_040458.xml","form_type":"4"}},{"id":4361991,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T19:22:08.000Z","date":"2017-04-02","kind":"exercise","acquired":true,"shares":1543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."}],"balance_after":3762,"source":{"system":"sec-edgar","filing":"0001415889-17-000592","document":"form4-04042017_040458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000592/form4-04042017_040458.xml","form_type":"4"}},{"id":4365108,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-03T17:14:30.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":4642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q1 2017."}],"balance_after":33060,"source":{"system":"sec-edgar","filing":"0001683168-17-000765","document":"maier_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316817000765/maier_f4.xml","form_type":"4"}},{"id":4496828,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-06T19:30:15.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":11250,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person, a non-employee director of the Issuer, as an annual equity grant for his service as a director of the Issuer. Such RSUs shall fully vest on the first anniversary of the grant date, January 5, 2018, and are subject to accelerated vesting upon a change of control of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":13854,"source":{"system":"sec-edgar","filing":"0001017491-17-000014","document":"wf-form4_148374900218648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000101749117000014/wf-form4_148374900218648.xml","form_type":"4"}},{"id":4508168,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-01-03T21:02:57.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":4100,"price":3.38,"value":13858.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such Options shall vest in equal annual installments over a three year period."}],"balance_after":4100,"derivative":{"exercise_price":3.38,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001415889-17-000024","document":"form4-01032017_060146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000024/form4-01032017_060146.xml","form_type":"4"}},{"id":4509692,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-30T19:59:28.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":7523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q4 2016"}],"balance_after":28418,"source":{"system":"sec-edgar","filing":"0001683168-16-001039","document":"maier_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316816001039/maier_f4.xml","form_type":"4"}},{"id":4538700,"issuer":{"id":7776,"kind":"organization","name":"FF EAI Robotics Ecosystem Inc."},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (2015 Equity Incentive Plan)","published_at":"2016-11-30T23:42:17.000Z","date":"2016-11-29","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Of the 7,000 shares granted, 730 shares were vested as of the grant date and the remaining 6,270 shares will vest ratably over the next 43 months."}],"balance_after":7000,"derivative":{"exercise_price":2.37,"expiration_date":"2026-11-29","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001382963-16-000265","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460702/000138296316000265/edgar.xml","form_type":"4"}},{"id":4579593,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T19:40:07.000Z","date":"2016-10-13","kind":"grant","acquired":true,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Stock granted as part of compensation for non-employee directors (Annual Grant), with vesting at the time of grant."}],"balance_after":20895,"source":{"system":"sec-edgar","filing":"0001683168-16-000323","document":"maier_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316816000323/maier_f4.xml","form_type":"4"}},{"id":4590710,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-03T16:33:57.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":10715,"price":0.3383,"value":3624.8845,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock were issued to the Reporting Person, a non-employee director of the Issuer, as partial payment for the quarterly retainer fee for his service as director of Issuer under an amended director compensation policy, which reduced the cash compensation payable to the Issuer's non-employee directors and in lieu of such cash compensation, resolved to grant shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The value of the shares being delivered in satisfaction of the payment was calculated based on the closing price of the Issuer's common stock on September 30, 2016."}],"balance_after":26039,"source":{"system":"sec-edgar","filing":"0001017491-16-000222","document":"wf-form4_147552682481299.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000101749116000222/wf-form4_147552682481299.xml","form_type":"4"}},{"id":4591683,"issuer":{"id":8432,"kind":"organization","name":"International Stem Cell CORP","symbol":"ISCO"},"owners":[{"id":18419,"kind":"person","name":"MAIER PAUL V","position":1,"cik":"0001182615","reported_name":"MAIER PAUL V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-30T20:53:39.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":4391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q3 2016."}],"balance_after":19561,"source":{"system":"sec-edgar","filing":"0001683168-16-000227","document":"maier_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182615/000168316816000227/maier_frm4.xml","form_type":"4"}}]}